StemCell Therapy

News

You can vote now for the winner of the 2020 Health Hero challenge.

You can start voting right now for the winner of the 2020 Be Well Philly Health Hero Challenge.

Were thrilled to announce that we now have our three finalists for the 2020 Be Well Philly Health Hero Challenge presented by Independence Blue Cross. Here at Be Well Philly, we constantly strive to highlight people who are helping others in the greater Philadelphia area live healthier and better lives. The Health Hero Challenge is our way of honoring the incredible and often unseen work that people do every day, even in the most challenging of circumstances.

We set out at the beginning of this challenge looking for medical providers, nonprofit leaders, entrepreneurs, teachers, anyone really whos making a difference in our community from a health and wellness perspective. And, you all delivered. You shared powerful personal stories of the heroes making a difference in our community, which led to to the nomination of these three finalists. Now, its time to choose the winner.

Name: Asasiya Muhammad (@thepeoplesmidwife), womens health advocate and midwife at Inner Circle Midwifery (@innercirclephilly), a private home birth practice based in Germantown.

Nonprofit of choice: Maternity Care Coalition. Since 1980, Maternity Care Coalition has assisted more than 135,000 families throughout Southeastern Pennsylvania, focusing particularly on neighborhoods with high rates of poverty, infant mortality, health disparities, and changing immigration patterns. A familys needs change as they go through pregnancy and their childs first years, and MCC offers a range of services and programs for every step along the way.

What motivates you to try to make Philadelphia a healthier place, and what policy would you institute if you could? I cherish Philadelphia as the place where I have had my most life-shaping experiences, some high such as graduating college, becoming a mother, and raising a family and others low. Ive had experiences that have left me feeling isolated, lost, and voiceless. As a Black mother, I have faced the feelings of fear and uncertainty many Black women in Philadelphia face, because of the haunting statistic that we are two times more likely to die during pregnancy, or within a year of giving birth due to pregnancy-related complications. As a midwife, I understand that the majority of these complications are preventable, and therefore have made it my mission to build a community-based a practice that is committed to diminishing this disparity in Philadelphia. My practice is unique in that it has a wraparound care component that bundles nutritional counseling and fitness classes into standard midwifery care.

I would institute a policy that expanded the use of and access to community-based providers and particularly related to those specializing in natural health and food access. This would look like expanding insurance access to providers like midwives, doulas, nutritional counselors, and fitness experts so that these services are both normalized and accessible to a larger part of the population. This would further look like creating sustainable food cooperatives in neighborhoods that are distant from larger markets and who now rely on stores that mostly carry processed foods.

Name: Vicky Borgia, a local doctor who utilizes Direct Primary Care (DPC), an alternative payment model for healthcare services. She specializes in reproductive health, LGBTQIA health and integrative medicine.

Nonprofit of choice: Womens Medical Fund. Racial justice and reproductive justice issues are intertwined. In 1976, Congress banned federal Medicaid coverage for abortion through the Hyde amendment. Then, in 1985, Pennsylvania prohibited state Medicaid coverage for abortion. Since then, Womens Medical Fund has provided funding to thousands of individuals struggling to get by and enrolled in Medicaid. Womens Medical Fund has expanded their mission to include advocacy and community organizing.

What motivates you to try and make Philadelphia a healthier place, and what policies would you institute if you could? I believe that healthcare is a human right. I serve communities that have historically been medically disenfranchised because I can use my skills and education to make changes in a system rife with health inequities. I center access, inclusion and equity in my direct primary care practice, which enables me to take the time I need with my patients and give the care they deserve.

Since it is well-established that racism and other forms of systemic oppression are major factors in increased morbidity, mortality, and generational trauma for all, my policy recommendations focus on dismantling systems of oppression in Philadelphia. This includes reprioritizing city investments from policing and instituting PILOTS where big health and educational nonprofits would volunteer a portion of their revenue to the general fund. These resources could be then be used to fund education and invest in communities by improving access to services, opportunities, food, and healthcare.

Name: Christy Silva, cofounder of Aidans Heart Foundation, a nonprofit committed to providing awareness, education, and support to the communities of the southeast Pennsylvania region and its surrounding area to create heart-safe communities for youth regarding the prevention of, or response to, tragic instances of Sudden Cardiac Arrest.

What motivates you to try to make Philadelphia a healthier place and what policy would you institute if you could ?

My motivation for wanting to make Greater Philadelphia a healthier place actually comes from a tragedy in my family. In September of 2010, my seven-year-old son Aidan, who had no prior health conditions, died without warning from sudden cardiac arrest, or SCA. I had never even heard of SCA prior to his death. As I struggled with my grief and tried to understand why my seemingly healthy child collapsed one sunny Saturday, I plunged into research. I learned that, nationally, approximately one out of every 300 youth has an undetected heart condition that could cause SCA. The American Heart Association quotes that more than 7,000 children under age 18 are struck by SCA each year. This equates to one young person, nearly every hour, every day, every year. Its a little known fact that Sudden Cardiac Arrest (SCA) is the leading cause of death in student athletes on school grounds. As a result of what I learned, I became determined to still be Aidans mom and try to prevent SCA from taking more young lives in our local communities. Im motivated by these facts to do everything possible to decrease the number of preventable deaths in young people in Philadelphia and its surrounding suburbs. I co-founded Aidans Heart Foundation shortly after Aidans death. To date, we have placed 89 AEDs in youth based sports facilities, trained 6,100 youth on how to perform CPR and how to use an AED, and we have partnered with pediatric cardiologists to provide 2,100 free heart screenings to kids and teens in efforts to detect heart conditions through a simple, non-invasive ECG exam.

If I could institute a policy to make Greater Philadelphia a healthier region, it would center around protecting hearts. Annual electrocardiogram exams at every well-child visit, particularly for young athletes; CPR and AED training for all teachers, coaches, instructors, etc. who work with physically active youth; and AED devices available in all schools, child care centers, dance, martial arts, gymnastics and other studios where kids are active, in addition to AEDs being prominently placed on every athletic playing field. These arent impossible tasks, but they do take the awareness of the public, particularly parents, to urge our community leaders and policymakers to implement these measures. We owe it to our kids to keep them safe at play.

Vote now to select your 2020 winner. Remember: the winner will be named the 2020 Health Hero and will receive a $15,000 donation to her charity of choice, and the two runners-up will each receive $2,500 donations to the charities of their choice.

Vote HERE now. (Remember, you can vote once a day until November 16th!) Stay in touch with @bewellphilly and @phillymagevents.

Read more here:
Meet This Year's Be Well Philly Health Hero Finalists - Philadelphia magazine

In an already high-stress year, this week just might take the top spot. Theres no easy way to calm down fast, but taking time to do some guided breathingwith the help of handy breathing videosmight help you feel a little better.

For many of us, the months leading up to Election Day have been a source of long-term, slow-burning stress, Christiane Brems, Ph.D., a registered yoga teacher, clinical professor, and director of YogaX at Stanford Psychiatry, tells SELF. This type of stresssustained and low gradecan wreak havoc on our nervous system, she says.

When your body is stressed, it releases the stress hormones adrenaline and cortisol, kicking off your fight-flight-freeze response, Manuela Kogon, M.D., clinical associate professor at the Stanford Center for Integrative Medicine, tells SELF. But purposeful breathing can trigger your parasympathetic system, or the part of your autonomic nervous system that opposes the fight-flight-freeze response. As a result, it may help you feel rested and relaxed.

Breathing is so powerful because unlike so many things in life, it's something we have control over, Rachel Allyn, Ph.D., a psychologist and yoga teacher based in Minneapolis, tells SELF. By improving the way you breathe, you can shift your nervous system from the stress-response mode to a state of regulation and relaxation.

And the good news is you dont need to do an extensive breathing routine to get the benefitsand you dont need to do them for a prolonged amount of time, either.

In fact, you can feel calming benefits in as little as 30 seconds of purposeful breathing exercises, Catherine Cook-Cottone, Ph.D. a licensed psychologist and registered yoga instructor based in Buffalo, New York, tells SELF. It doesnt need to be complicated, she says. Orienting back to your own breathjust noticing itis a powerful first step.

For a little more structure, check out these 17 expert-approved breathing videos to help you get started.

Length: 9 minutes

What to expect: This guided meditation cultivates focus and stability through concentration and mindfulness with breathing.

I like this simple technique of paying attention to the gap between your exhale and inhale. It is so calming and the time floats by, leaving you feeling clear and aware when complete. Diane Malaspina, Ph.D, psychologist, yoga teacher, and therapeutic specialist in Virginia Beach, Virginia

Try the breathing routine.

Length: 3 minutes

What to expect: Gabby Bernstein, New York Times best-selling author and kundalini yoga and meditation teacher, shares a calming five-count breathing technique.

This three-minute video is great for a technique called box breath, where we silently count to five on the inhale, hold the inhale to a count of five, exhale for five, and hold our breath for a count of five (before the next inhale to a count of five). Beyond the immediate sense of calm it brings, the box breath is easy to do anywhere and enhances feelings of relaxation and peace. Diane Malaspina

Try the breathing routine.

Length: 4 minutes

What to expect: Thich Nhat Hanh guides you through the first exercises of mindful breathing, from following the in breath and out breath all the way through to generating the energy of mindfulness by being with your body.

I love this video because Thich Nhat Nahn, one of the most profound teachers, makes the breathing exercises simple and approachable. With these practices, we find the magic in the simple act of breathing. Laurasia Mattingly, meditation and mindfulness teacher and founder of the Sit Society in Los Angeles

Originally posted here:
17 Breathing Videos That Will Help You Relax and Unwind - Self

Maui Grown Therapies has announced to organize a webinar titled, Cannabis and the Anti-Inflammatory Lifestyle that is going to be held on November 5. There are no charges imposed on participation in this webinar. The event will take place from 11:00 (HST) to 2:00 (PST) and it will be presented by Dr. Andrew Weil.

Andrew Weil is the MD, founder, and director of the Andrew Weil Center for Integrative Medicine at the University of Arizona. In addition to this, he is the chief science officer for Maui Grown Therapies. He has always endorsed the importance of living an anti-inflammatory lifestyle to get rid of many health problems.

In the webinar, Cannabis and the Anti-Inflammatory Lifestyle, participants will learn important information about reducing inflammation. Moreover, they will know about the ways to boost the natural defense mechanisms of the body.

Additionally, the light will be thrown on the subject of the importance of various compounds present in the cannabis plants namely, CBD, THC, and terpenes. The webinar will conclude with a live Q&A after the online presentation on the subject of living an inflammatory lifestyle.

Dr. Andrew Weil has been endorsing the anti-inflammatory lifestyle for a long time. He conducted the first human trials in the nation using various cannabis products. Dr. Weil has gained global recognition for his worthy contribution to integrative medicine.

He completed his undergraduate degree in botany from Harvard and gained his M.D from Harvard Medical School. Dr. Weil always endorses the consumption of cannabis seeds to gain healthy fats and essential fatty acids.

He is associated with Maui Grown Therapies, Hawaiis first state-licensed medical cannabis dispensary, to spread awareness about living an anti-inflammatory lifestyle by consuming various cannabis products. Know more about the webinar and register for the webinar by clicking the links mentioned below.

Register for the Webinarhttps://manao.mauigrown.com/maui-grown-manao

Youtube Linkhttps://www.youtube.com/watch?v=yz8ryqanQDM

Read More Here

YOUR GUIDE TO CANNABIS & THE ANTI-INFLAMMATORY LIFESTYLE

Your Guide to Cannabis and an Anti-Inflammatory Lifestyle by THE MEDIA BUTLER

Address

Maui Grown Therapies44 Paa St, Kahului, HI 96732(808) 866-7576

Link:
Maui Grown Therapies to Organize a Webinar on Cannabis Hosted by Dr. Andrew Weil on November 5 - London Daily Post

Nov. 5, 2020 09:00 UTC

BOSTON & LONDON--(BUSINESS WIRE)-- Synthace Ltd and Ipsen, a global biopharmaceutical company focused on innovation and specialty care, have partnered to accelerate development of novel biotherapeutics targeting multiple therapeutic areas, including oncology, endocrinology, pain management, regenerative medicine and rare diseases. Ipsen has automated design and construction of therapeutic candidates using Synthaces integrative software platform, Antha. The process aims to speed up biotherapeutic candidate entry into the screening pipeline and shorten development time for treatment of diseases via targeted secretion inhibition.

Ipsen has developed novel biotherapeutic molecules, called Targeted Secretion Inhibitors (TSIs). TSIs are a fusion of select parts of the botulinum neurotoxin with another protein domain to redirect its mode of action, resulting in a unique targeted therapeutic. The design and construction of TSIs is both labour intensive and manually complex, typically taking 30 days to develop between 24-48 constructs which then go on to therapeutic screening.

The Ipsen R&D team required a solution to increase throughput and efficiency of its TSI generation and screening pipeline, while utilizing its Type IIs construct assembly method. They looked to fellow innovators Synthace, whose flexible and integrative software Antha has built-in workflows for automating processes such as Type II construct assembly, bacterial transformation, plating, data generation and analysis.

Synthaces Antha platform allowed the Ipsen team to plan, simulate, and test their assemblies in silico before executing the protocol. The partnership of Antha and Ipsen produced approximately 90 constructs five times faster than previous methods, substantially increasing the number of molecules entering the screening cascade. Antha was also able to increase efficiency by re-using core DNA building blocks for multiple construct assemblies, resulting in a 10-fold reduction in costs associated with DNA synthesis.

Dr. Karen Bunting, Director of Protein Science at Ipsen said, The development of novel biotherapeutics like TSI is key to treating debilitating illnesses across multiple therapeutic areas. The first step in this is generating and screening high quality molecules as therapeutic candidates. Using Antha, our team increased throughput at this crucial step, allowing us to design, construct, and screen novel TSI candidates rapidly and helping to advance our therapeutic solutions.

Drug discovery is a costly and laborious process where thousands of candidates are generated, screened and validated, but only a select few are chosen to move forward in the pipeline. Pharma companies are turning to automation and software to aid in the design, construction and screening of these compounds, reducing costs and increasing efficiency without compromising on quality.

To achieve this, biopharmaceutical companies like Ipsen are partnering with specialists in integrating the digital and physical aspects of R&D, providing an easy-to-use interface between scientists, design software, automated devices, and data handling downstream. This flexible, integrated approach to the discovery process has clear advantages in boosting efficiency at the earliest stages of drug development, with the ultimate goal of making more effective treatment options available to patients sooner.

Dr. Tim Fell, CEO of Synthace concluded, We are thrilled to see our Antha platform applied to develop new biotherapeutics. Antha has accelerated Ipsens TSI construction and screening programme while reducing costs and the time scientists spent in the lab. Automating processes like these allows scientists to focus on experimental design and data analysis rather than liquid handling, enabling them to create more beneficial therapeutics for patients,.

To learn more about automating drug discovery and development protocols, visit: https://www.synthace.com/customers/case-studies/detail/construct-assembly-for-the-development-of-new-therapeutics-with-ipsen/

Follow Synthace Synthace Blog Join the Twitter Conversation Join us on LinkedIn

About Synthace Based in London, UK and Boston, US, Synthace is accelerating biological discovery & optimization through computer-aided biology. Our cloud software platform, Antha, empowers biologists by enabling them to flexibly program their lab automation without the need to code. The graphical user interface has been designed by biologists for biologists, intuitively enabling them to automate their whole experiment from planning to execution, data collection and analysis. Antha is the cornerstone of the lab of the future, seamlessly connecting the digital realm of data with the physical of lab automation and wet-lab biology, automatically collecting and structuring data to accelerate biological understanding.

Synthace is unlocking the potential of biology for humankind and our environment. Synthace works with biopharmaceutical companies, and in 2016 was recognized by the World Economic Forum as a Technology Pioneer that is helping shape the Fourth Industrial Revolution, and in 2018 as a cool vendor by Gartner.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201105005418/en/

Original post:
Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development Through Automation - BioSpace

CHICAGO, Nov. 3, 2020 /PRNewswire/ --At the 2020 Concierge Medicine Forum (CMF), Terry Bauer, CEO of Specialdocs Consultants, a pioneer in concierge medicine transitions and management, along with a group of the company's outstanding physician-clients, will share an inside look at the practice model that continues to fuel one of the healthcare industry's rare success stories in a year of unprecedented challenge. A completely virtual experience for the first time, the highly anticipated annual industry event spans three days of presentations, workshops and live chat sessions with concierge industry leaders; all focused on the relevant theme of collaboration in medicine.

"At this pivotal point in healthcare, we are privileged to share our collective experience and stories of transformation."

"This year has exposed the vulnerabilities of traditional fee-for-service practices in ways we could never have foreseen," says Bauer. "And 2020 has also underscored the resilience and rewards of the Specialdocs model of personalized medicine and inspired rising numbers of physicians to consider this beneficial alternative for themselves and their patients. At this pivotal point in American healthcare, we are privileged to share with Concierge Medicine Forum attendees our collective experience and first-person stories of transformation from our network of dedicated doctors."

Michael Tetreault, CMF organizer and editor of Concierge Medicine Today, says: "The virtual format enables us to host a more diverse gathering of healthcare professionals than ever before, and offer 24/7 on-demand access to insights from the industry's most creative minds. We're thrilled to feature groups like Specialdocs, pioneers and continual innovators in the concierge medicine space."

Specialdocs will be featured at events including: (all ET)

Thursday, Nov. 12th Pre-conference workshop

Friday, Nov. 13th

After 2 pm

Saturday, Nov. 14th

Since 2002, concierge medicine transition and management experts Specialdocs Consultants have helped physicians nationwide transform their practices with a uniquely customized and sustainable concierge model.

Contact: Mindy Kolof, mkolof@specialdocs.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/specialdocs-informs-and-inspires-at-concierge-medicine-industrys-signature-event-nov-12th--14th-301166040.html

SOURCE Specialdocs Consultants

Read the original post:
Specialdocs Informs and Inspires at Concierge Medicine Industry's Signature Event Nov. 12th - 14th - Benzinga

Maui Grown Therapies webinar titled, Cannabis and the Anti-Inflammatory Lifestyle is scheduled to take place on November 5. It will be presented by Andrew Weil who is MD, founder, and director of the Andrew Weil Center for Integrative Medicine at the University of Arizona and chief science offer for Maui Grown Therapies.

Maui Grown Therapy is Hawaiis first state-licensed medical cannabis dispensary. The timing of the webinar is set at 11:00 (HST) to 2:00 (PST) on Thursday, Nov. 5, 2020. The webinar will highlight the importance of living an anti-inflammatory lifestyle to improve overall health and wellness. It will end with a live Q&A post the online presentation.

Dr. Andrew Weil has always supported the anti-inflammatory lifestyle to live a healthy life. He is globally renowned for his pioneering work in integrative medicine. He earned his undergraduate degree in botany from Harvard and he completed his M.D. from Harvard Medical School. It was in 1969 when Dr. Weil conducted the nations first human trials with the use of cannabis.

The participants of the webinar, Cannabis and the Anti-Inflammatory Lifestyle will learn ways to reduce inflammation and boost the natural defense mechanisms of the body. In addition to this, the value of compounds in cannabis plants such as CBD, THC, and terpenes will also be discussed.

Dr. Weil also recommends consuming cannabis seeds (edible hemp seeds) as a rich source of healthy fats and essential fatty acids. They are an excellent protein source that contains vitamin E, phosphorus, potassium, sodium, magnesium, sulfur, calcium, iron and zinc.

Register for the Webinar https://manao.mauigrown.com/maui-grown-manao

Youtube Link https://www.youtube.com/watch?v=yz8ryqanQDM

Read More Here

YOUR GUIDE TO CANNABIS & THE ANTI-INFLAMMATORY LIFESTYLE

Your Guide to Cannabis and an Anti-Inflammatory Lifestyle by THE MEDIA BUTLER

Address

Maui Grown Therapies44 Paa St, Kahului, HI 96732(808) 866-7576

Read this article:
Maui Grown Therapies' Webinar, Cannabis and the Anti-inflammatory Lifestyle to be Held on Nov. 5 - California Herald

Daylight saving time ends on Nov. 1 at 2 a.m. While many simply see this as gaining an hour of sleep on Sunday, there are various lasting effects that this time change will bring, both mentally and physically. Yahoo Life is joined by two experts who share what to expect and ways to combat the negative effects.

Integrative medicine physician and wellness expert Dr. Taz Bhatia explains that when we set the clocks back, were also adjusting our internal clock and throwing off our circadian rhythm.

Our circadian rhythms, or the flow of when we sleep and when were awake, dictates so many different processes in the body, says Bhatia.

When our circadian rhythms are thrown off, our sleep cycles become inconsistent, our weight is less regulated due to a change in insulin, and the risk of heart disease, stroke and heart attack increases.

Judy Ho, a licensed clinical and forensic neuropsychologist, highlights how experiencing one less hour of light each day can heavily impact ones mood, causing us to experience more depression and sadness.

So what can we do to cope with these changes? During the day, its crucial to take advantage of any kind of sunlight, whether its indirectly through a window or through a sun lamp as light therapy has been proven to work wonders on mood and sleep.

With less sunlight during the day, we also receive less vitamin D, also known as the sunshine vitamin. We can, however, make up for the lack of vitamin D in other ways. It's important now more than ever to exercise regularly, as it helps with the endorphin release and boosts our mood, says Bhatia.

Ho recommends establishing a calming nighttime routine that involves putting away all devices, especially blue light devices. To combat sleep deprivation, people should go to bed earlier, but not too early.

You dont want to go to bed too early just to make sure that youre in bed by a certain hour because then you might be awake for longer than you need to be, Ho explains. Then the bed becomes associated with anxiety and stress.

Since 2020 has been anxiety-inducing for many, Bhatia points out that our threshold for anxiety and depression is lower right now.

When we have additional disruptions like disruptions to our sleep cycle, disruptions to the amount of light we're getting in when we're awake, its just one more factor in an already really tough year for so many people, she says.

Ho reiterates how beneficial it is to maintain social connections on a daily basis with friends and loved ones.

Even a brief interaction like that can bring you a lot of positivity and feeling of community when you need it most, she says.

Video produced by Jenny Miller

Read more from Yahoo Life:

Want lifestyle and wellness news delivered to your inbox?Sign up herefor Yahoo Lifes newsletter.

Read the original:
Daylight Saving Time: What happens to your body when we fall back - Yahoo Canada Shine On

On Oct. 14 2020, in Ocean City, Car Caress was named Best Auto or Boat Detailer for this years Best of The Press contest.

When you buy a new car, it has that crisp, clean smell of wax, leather and upholstery. But over time, that fresh scent can be overtaken by cigarettes, fast food, spilled coffee and pet odors.

If the thought of cleaning your car seems overwhelming, take it to Car Caress Custom Auto Detailing, which earned Best of the Press in the Automotive/Transportation category.

Owner Brian Coggins is honored by the accolade and owes his success to his employees.

Customer services is No. 1, and that makes all the difference. I have a good group of people working for me, he says. I cant do everything myself. They do a great job.

With three locations Ocean City, Marmora and Somers Point Car Caress restores vehicles with services that shine, buff, polish and freshen your car or boat, inside and out.

Services include detailing; ceramic coating, a longer-lasting way to protect the paint than wax alone; ozone treatment, which disinfects and destroys bacteria in your car and the ventilation system; and automatic car washing.

Car detailing along with these other services requires a desire for perfection.

You have to be picky to do this kind of work, says Coggins. Youre not there just to make it look OK. You want to get the car or boat looking perfect. So you have to get into all the cracks and crevices.

It also takes skill, particularly buffing the car or boat.

Buffing isnt using a rag to shine something, Coggins explains. Theres a high-speed rotary buffer that runs at 1,500 rpms to 2,000 rpms. Using this machinery requires real craftsmanship, says Coggins, because if you dont know what youre doing, you can scratch the car and do damage.

For these reasons, Coggins is grateful most of his 15 employees stayed with him, even while his business was closed during quarantine.

Although COVID-19 sidelined Car Caress, it has created a silver lining for the family-owned business, namely sanitizing vehicles. Coggins explains the difference between cleaning and sanitizing.

With sanitizing, youre killing the germs and bacteria that are on the surfaces of whatever youre cleaning. When youre cleaning with a regular soap, youre not necessarily killing all the germs, he says.

Thats where ozone cleaning comes in, a service thats becoming increasingly more popular now that COVID-19 is a way of life. Ozone is a gas that removes odors, as well as disinfects and destroys viruses and bacteria. Unlike a liquid disinfectant, ozone gets into the places you cant clean, including the ventilation and AC systems, carpet fibers and upholstery.

Customers are requesting this service more, as well as used car dealerships, and those in the private transportation business, such as Uber drivers.

Although coping with COVID-19 was difficult during quarantine, Coggins biggest challenge still is operating a seasonal business.

Summers are super busy here, he Coggins. We hire summer workers, and it takes a while for them to learn. Just when they start getting good at this, they go home and leave.

Thats why Coggins is grateful to his employees, who take the sting out of summer workers departures.

The guys I have are really good, and most came back after quarantine, which was nice. I owe this (Best of The Press) to them, he says.

Read the original here:
Who are this year's Best of the Press? - Press of Atlantic City

NORTH CHICAGO, Ill., Nov. 5, 2020 /PRNewswire/ --AbbVie (NYSE: ABBV) announced that it will present blood cancer data from nearly 40 abstracts, including 10 oral presentations, across 11 cancer types during the upcoming virtual American Society of Hematology (ASH) Annual Meeting and Exposition, December 5-8.

"We are steadfast in our commitment to advancing discovery, innovation and care for people with blood cancers," said Mohamed Zaki, M.D., Ph.D, vice president and global head of oncology development, AbbVie. "We are looking forward to sharing findings from our expanding hematology oncology portfolio and continued research and treatment advances during the ASH annual meeting."

AbbVie will present updated results from the CAPTIVATE study, evaluating disease-free survival in previously untreated patients with chronic lymphocyctic leukemia (CLL)/small lymphocytic leukemia (SLL) who received an ibrutinib (IMBRUVICA) + venetoclax (VENCLEXTA/ VENCLYXTO) combination regimen. As well, an update on a 5-year analysis of the MURANO study in a subset of relapsed/refractory CLL patients following venetoclax-(VENCLEXTA/ VENCLYXTO) rituximab therapy and 8-year follow-up ibrutinib (IMBRUVICA) data in high-risk patients with CLL (RESONATE-2 and iLLUMINATE) will be presented. AbbVie's new partners, Genmab and I-Mab will offer data from recently announced collaborations.

Details about presentations are as follows:

Abstract

Presentation Details

All times CT

Ibrutinib

Ibrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): 1-Year Disease-Free Survival (DFS) Results From the MRD Cohort of the Phase 2 CAPTIVATE Study

Session 642. CLL: Therapy, excluding TransplantationSaturday, December 5Session: 9:30 a.m. - 11:00 a.m.Oral Presentation: 11:30 a.m.

Five-Year Follow-Up of Ibrutinib Plus Rituximab vs Placebo Plus Rituximab for Waldenstrom's Macroglobulinemia: Final Analysis From the Randomized Phase 3 iNNOVATE Study

Session 623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Clinical studies in Waldenstrom's Macroglobulinemia, Marginal Zone Lymphoma and Hairy Cell LeukemiaSunday, December 6Session: 9:30 a.m. - 11:00 a.m.Oral Presentation: 11:30 a.m.

Rarity of B-Cell Receptor Pathway Mutations in Progression-Free Patients With Chronic Lymphocytic Leukemia (CLL) During First-Line Versus Relapsed/Refractory (R/R) Treatment With Ibrutinib (Ibr)

Session 642. CLL: Therapy, excluding Transplantation: Poster II

Sunday, December 6

Outcomes of First-Line Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and High-Risk Genomic Features With Up To 6.5 Years Follow-Up: Integrated Analysis of Two Phase 3 Studies (RESONATE-2 and iLLUMINATE)

Session 642. CLL: Therapy, excluding Transplantation: Poster IISunday, December 6

Long-Term Efficacy of First-line Ibrutinib Treatment for Chronic Lymphocytic Leukemia (CLL) With 4 Years of Follow-Up in Patients With TP53 Aberrations (del(17p) or TP53 Mutation): A Pooled Analysis From 4 Clinical Trials

Session 642. CLL: Therapy, excluding Transplantation: Poster II

Sunday, December 6

Real-World Prognostic Biomarker Testing, Treatment Patterns and Dosing Among 1461 Patients (pts) with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) from the informCLL Prospective Observational Registry

Session 642. CLL: Therapy, excluding Transplantation: Poster IIMonday, December 7,Session: 7:00 a.m. 8:30 a.m.Oral Presentation: 10:15 a.m.

Ibrutinib Plus Venetoclax in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Results From the Safety Run-In Period of the Phase 3 SYMPATICO Study

Session 623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III

Monday, December 7

Long-Term Follow-Up of Ibrutinib Treatment for Rituximab-Refractory Waldenstrm's Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATE Trial

Session 623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster IIIMonday, December 7

Venetoclax in Acute Myeloid Leukemia (AML)

Venetoclax Crosses the Blood Brain Barrier: A Pharmacokinetic Analysis of the Cerebrospinal Fluid in Pediatric Leukemia Patients

Session 613. Acute Myeloid Leukemia: Clinical Studies: Poster I

Saturday, December 5

Venetoclax Alone or in Combination with Chemotherapy: Responses in Pediatric Patients with Relapsed/Refractory Acute Myeloid Leukemia with Heterogenous Genomic Profiles

Session 615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I

Saturday, December 5

Proposed Scheme for Dosing Venetoclax in Pediatric Patients with Relapsed/Refractory Acute Myeloid Leukemia: Analysis of Developmental Pharmacokinetics and Exposure-Response Relationships

Session 613. Acute Myeloid Leukemia: Clinical Studies: Poster I

Saturday, December 5

Results of Venetoclax and Azacitidine Combination in Chemotherapy Ineligible Untreated Patients with Acute Myeloid Leukemia with IDH 1/2 Mutations

Session 613. Acute Myeloid Leukemia: Potpourri of Potential Practice Changing Studies

Sunday, December 6

Session: 9:00 a.m. - 5:30 p.m.

Oral Presentation: 4:45 p.m.

Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia in the Expansion Cohort of a Phase 1b Study

Session 613. Acute Myeloid Leukemia: Novel Therapies and Treatment Approaches

Sunday, December 6

Session: 9:00 a.m. - 5:30 p.m.

Oral Presentation: 12:15 p.m.

Cytopenia Management in Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax Plus Azacitidine in the VIALE-A Study

Session 615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II

Sunday, December 6

Characteristics and Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Receiving Venetoclax Combinations vs Other Therapies: Results from the AML Real World EvidenCe (ARC) Initiative

Session 906. Outcomes ResearchMalignant Conditions (Myeloid Disease): Poster II

Sunday, December 6

Results of Venetoclax and Azacitidine Combination in Chemotherapy Ineligible Untreated Patients with Acute Myeloid Leukemia with FLT3 Mutations

Session 613. Acute Myeloid Leukemia: Clinical Studies: Poster IISunday, December 6

Real-World Treatment Patterns and Clinical Outcomes in Unfit Patients with AML Receiving First-Line Systemic Treatment or Best Supportive Care (CURRENT): Final Analysis

Session 613. Acute Myeloid Leukemia: Clinical Studies: Poster II

Sunday, December 6

First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) REVIVE Study

Session 613. Acute Myeloid Leukemia: Clinical Studies: Poster III

Monday, December 7

CYP3A Inhibitors and Impact of These Agents on Outcomes in Patients with Acute Myeloid Leukemia Treated with Venetoclax Plus Azacitidine on the VIALE-A Study

Session 615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster III

Monday, December 7

Venetoclax in Acute Lymphoblastic Leukemia (ALL)

Venetoclax and Navitoclax in Pediatric Patients With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Session 614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Targeted Therapies

Sunday, December 6

Session: 9:00 a.m. - 5:30 p.m.

Oral Presentation: 4:30 p.m.

Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia Harboring Heterogenous Genomic Profiles Respond to Venetoclax in Combination with Chemotherapy

Session 612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster III

Monday, December 7

Venetoclax in Chronic Lymphocytic Leukemia (CLL)

Five-Year Analysis of MURANO Study Demonstrates Enduring uMRD in a Subset of Relapsed/Refractory (R/R) CLL Patients Following Fixed Duration Venetoclax-Rituximab Therapy

Session 642. CLL: Therapy, excluding Transplantation

Saturday, December 5

Session: 9:00 a.m.- 5:30 p.m.Oral Presentation: 12:00 p.m.

Clonal Dynamics After Venetoclax-Obinutuzumab Therapy: Novel Insights From the Randomized, Phase 3 CLL14 Trial

Session 642. CLL: Therapy, excluding Transplantation

Saturday, December 5

Session: 9:00 a.m. - 5:30 p.m.

Oral Presentation: 12:30 p.m.

Characteristics and Outcome of Patients with Chronic Lymphocytic Leukaemia and Partial Response to Venetoclax-Oinutuzumab

Session 642. CLL: Therapy, excluding Transplantation: Poster I

Saturday, December 5

Assessment of Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated With Venetoclax in the Clinical and Post-Marketing Settings

Session 642. CLL: Therapy, excluding Transplantation: Poster II

Sunday, December 6

Efficacy of Subsequent Novel Targeted Therapies, Including Repeat Venetoclax-Rituximab (VenR), in Patients with Relapsed/Refractory CLL Previously Treated With VenR in the MURANO Study

Session 642. CLL: Therapy, excluding Transplantation: Poster III

Monday, December 7

Visit link:
AbbVie to Highlight Blood Cancer Leadership and Advancing Oncology Pipeline at the ASH 62ND Annual Meeting - WFMZ Allentown

PARIS, Oct. 28, 2020 /PRNewswire/ -- Rarecells, Inc. (USA), a leading Liquid Biopsy company, is pleased to announce thatNational Institute of Integrative Medicine's (Melbourne, Australia) researchers obtained striking results in a group of Australian men using the ISET test for early prostate cancer diagnosis through the detection of Prostate-Specific Antigen (PSA)positive Circulating Tumor Cells (CTC).

The peer-reviewed article published in the journalFrontiers in Oncology (article), shows that the prostate cancer test based on CTC harvested with the ISET technology and identified by the Immuno-Cytochemistry (ICC) PSA marker has an estimated positive-predictive-value (PPV) of 99% and negative-predictive-value (NPV) of 97%, providing a more reliable screening test for prostate cancer than the standard PSA blood test (PPV = 25%; NPV = 15.5%).

Prostate cancer is the second most common cancer and the fifth leading cause of cancer deaths in men worldwide. Due to the limited sensitivity and specificity of the standard PSA test, a relevant proportion, close to 75%, of unnecessary prostate biopsies are performed every year, generating avoidable costs and suffering.

"This new non-invasive test based on ISET technology allows for early detection of prostate cancer more accurately than the standard PSA test. Improving the accuracy of tests for early cancer detection may reduce the burden of unnecessary biopsies," said NIIM Director of Research, and Chief Investigator Associate Professor Karin Ried.

Davide Brechot, Deputy Director and CTO at Rarecells commented: "NIIM's preliminary data obtained with the ISET technology opens the way to a more reliable prostate cancer screening test driving earlier curative interventions while reducing unnecessary, painful and costly prostate biopsies.They add to the body of published evidence of ISET technology's excellence in cancer diagnostics and management"

ISET has been validated by more than 85 independent scientific publications on 3,400 cancer patients and more than 1,200 cancer-free individuals (see http://www.rarecells.com). It demonstrates unparalleled performance for the isolation and characterization of individual CTC and CTC clusters.

About RARECELLS (www.rarecells.com)

Rarecells develops high value, innovative diagnostic tests in the fields of liquid biopsy and early cancer diagnostics. The company is the exclusive licensee of the ISET patent portfolios owned by University of Paris, INSERM and Assistance Publique-Hpitaux de Paris (AP-HP).

Logo - https://mma.prnewswire.com/media/1280816/Rarecells_Diagnostics_Logo.jpg

Contact@rarecells.com

More:
ISET test results show substantial improvement in early detection of prostate cancer by identifying PSA-positive Circulating Tumor Cells - WFMZ...

When it comes to fighting inflammation with diet, following a specific program is not a necessity. In fact, many of the so-called anti-inflammatory diets are more hype than real science. That said, a couple of diets round up all the anti-inflammatory elements into one eating plan and have more evidence of benefit than other diets. If you aren't sure where to start, these diets are good choices.

People who live in countries ringing the Mediterranean Sea, like Italy and Greece, have traditionally eaten a diet consisting mainly of fruits and vegetables, nuts and seeds, whole grains, fish, and olive oil the same foods that experts recommend to bring down inflammation. Over the years, researchers began to discover that people who followed this style of eating had lower rates of disease and lived longer than people in the United States who ate a Western-style diet.

The Mediterranean diet is ranked high among doctors and dietitians, and for good reason. Studies show it protects against diseases linked to inflammation, including cardiovascular disease, metabolic syndrome, and type 2 diabetes. And, because it includes a variety of foods, the Mediterranean diet is relatively easy to follow and stick with.

Although its name may suggest the "grab-and-go" section of the supermarket, DASH is anything but a fast-food regimen. DASH stands for Dietary Approaches to Stop Hypertension. It was originally developed to lower blood pressure without medication, but is now widely considered to be one of the healthiest eating patterns around. It includes foods low in total fat, saturated fat, and cholesterol, and lots of fruits, vegetables, and whole grains. Protein is supplied by low-fat dairy, fish, poultry, and nuts. Red meat, sweets, and sugary drinks are limited. DASH is high in fiber, potassium, calcium, and magnesium and low in sodium.

Another anti-inflammatory diet with science to back it up comes from Harvard-educated integrative medicine practitioner Dr. Andrew Weil. He started talking up anti-inflammatory measures decades ago, long before the idea began trending. His anti-inflammatory diet could be described as a Mediterranean diet with Asian influences. About 40% to 50% of calories come from carbohydrates, 30% from fat, and 20% to 30% from protein.

Where Dr. Weil's diet wins is in its emphasis on plant-based foods and healthy protein sources, as well as specific elements (fatty fish, fruits, vegetables, oils, nuts, and seeds) that help to reduce inflammation. It also minimizes highly processed foods, which can contribute to inflammation.

For additional advice about ways to reduce inflammation, read Fighting Inflammation, Special Health Report from Harvard Medical School.

Image: OksanaKiianGetty Images

Disclaimer:As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

More:
The best anti-inflammatory diets - Harvard Health - Harvard Health

Viewers Kati Lucas and Kimberly Horton are joining 3News Meteorologist Jason Frazer on a healthy living journey with Cleveland Clinic's Wellness Center

The Coronavirus pandemic has brought many challenges, and if it's also taken a toll on your physical and mental health, you're definitely not alone.

That's why 3News is launching a new series "The New You" with Jason Frazer and Cleveland Clinic's Wellness Center. And we're inviting two special 3News viewers along for the journey.

Meet Kati Lucas. She's a busy mom of three in her late forties, who also works as a nurse.

"I'm just busy, busy, busy bee running around and dealing with [everything] and then I come last. Then by the time I realize I need to take care of me, I'm dead tired," Kati said.

That's a feeling Kim Horton can relate to. She's in her early sixties, retired for the last few years, but mom to two grown kids and proud grandma to her first grandson. She told us, she's ready to make a change.

"At some point in your life, you got to say it's time out for fear and those things that keep you from moving forward, and maybe this is going to help me move forward."

Kati and Kim both told us the pandemic has brought additional challenges to lifelong struggles with their weight.

"This year's just been challenging on many fronts for me personally and I want to feel better. I'm sick and tired of feeling sick and tired," said Kati.

These are smart successful women. They're active too. Kim told 3News she's always been athletic.

"I consider myself still an athlete [and] my husband and I play tennis at least two or three times a week," she said.

They also are well aware of the importance of making healthy choices.

"[As a nurse] I understand how obesity can lead to inflammation and inflammation can lead to disease and so forth," said Kati.

Yet, like so many of us, both Kati and Kim have struggled to make a lifestyle change until now. That's where Cleveland Clinic's Wellness Center comes in.

"In the center of integrative and lifestyle medicine we try to address not just physical pain or physical symptoms but also look at emotional health," said Dr. Irina Todorov, Interim Medical Director for the Center of Integrative and Lifestyle Medicine.

Over the next eight weeks, Jason, Kati and Kim will have an opportunity to work with the Center to take a mind, body and spirit approach to healthier living.

"The goal of the program is to learn lifelong habits. The first week may be a nutrition consult, the second week will be massage therapy, the third week will be acupuncture, [for example], she said.

"I'm humble enough to admit that I need help...I saw this as a perfect opportunity to to just get my butt ingear and just reclaim a sense of agency about myself," Kati told us.

"Sometimes doggone it, you got to be selfish," laughed Kim. "And just say this is what I have to do for me."

They're ready to go, and we hope you'll follow along too.

View original post here:
'The New You'| Meet Kati and Kim and follow their health journey - WKYC.com

LOS ANGELES GTs Synergythe beloved and world-renowned Kombucha brand, today announced a partnership withChopra Global, a leading whole health platform founded by Dr. Deepak Chopra. GTs Synergy is the first-ever branded content partner of Chopra Global; the two brands are joining forces in support of GTs recently launched Rooted In Nature campaign to reinforce the message thatholistic health for mind, body, and soul are all rooted in the natural world.

GTs Synergy and Chopra Global aim to provide the world with tools and resources for mental health and wellness maintenance. Starting today, new GTs email subscribers can receive free GTs Synergy Kombucha and a complimentary 1-year membership to Chopra Globals new Meditation and Well-Being App, while supplies last. The Chopra App features a comprehensive library of simple self-care guidance and meditations for mind, body and spirit to help create and sustain a healthier life. Chopra Global launched its app offering in September and is currently available on iOS.

At GTs, everything we do is rooted in our mission to be a guide and helping hand for peoples health & wellness journeys. With Chopra Global by our side as part of our Rooted In Nature campaign, together we can reach even more people to share a message that a healthy mind is just as important as a healthy body, says GT Dave, Founder and CEO of GTs Living Foods. For 25 years, Chopra Global and GTs alike have pioneered our respective industries with approaches inspired by Eastern philosophies and the natural world. Now more than ever, in our increasingly modern lives, so many people are losing that connection to nature and self-care. We are honored and grateful to partner with Chopra Global to emphasize the importance of Mother Nature and meditation as part of a healthier, more holistic way of living.

Many brands market their commitment to the consumers well-being, yet few actually invest in that mission, says Tonia OConnor, CEO of Chopra Global. GTs, like Chopra Global, was founded on the platform of advancing well-being and promoting healthy lifestyles. Offering their subscribers free access to our new well-being and meditation subscription app further demonstrates GTs dedication to serving its customers. We are thrilled to partner with a company that values Chopra Globals self-care guidance and the opportunity to share a co-produced content series with new audiences in different formats.

For more than two decades, Chopra Global has been at the forefront of health and wellness, empowering personal transformation for millions of people worldwide to expand our collective well-being. Anchored by the lifes practice and research of Dr.Deepak Chopra, a pioneer in the fields of integrative medicine, consciousness, and meditation, Chopra Globals signature programs have been proven to improve overall well-being through a focus on physical, mental, and spiritual health.

Additionally, GTs will present a special Chopra Globalco-produced digital meditation series in November that will offer bite-sized guided meditations focused on gratitude and the importance of being in nature. The series will feature Chopra Globals trained and certified instructors along with special appearances fromChopra Global CEO Tonia OConnor, and the health and wellness pioneer himself,GT Dave.

GTs Meditation Series will be completely free and available via GTs and Chopra Globals social channels.

For more information on GTs Living Foods and the Chopra Global partnership, please visit:GTsLivingFoods.com/rootedand follow along on social media: @GTsKombucha.

About GTs Living Foods:

We believe that Mother Nature is the Worlds greatest healer. Since 1995, GTs Living Foods has revolutionized how people think and feel about Kombucha and fermented foods in the Western World. From the womb, founder GT Dave was raised vegetarian and taught that food can be medicine. He continues to uphold that philosophy with always pure, potent, and plant-derived fermented offerings produced in their most authentic form, never compromised. The fiercely independent, family-owned, and operated company is available in over 55,000 retailers across North America and Europe. Today and beyond, GTs Living Foods driving purpose is to spread a global message that food can be medicine and through proper nutrition, one can heal thyself. For more information, please visitgtslivingfoods.com.For more information, interact with the team onFacebook,TwitterandInstagram.

About Chopra Global:

Chopra Global is a leading whole health company that is empowering personal transformation for millions of people globally to expand our collective well-being. Anchored by the lifes practice and research of Dr.Deepak Chopra, a pioneer in integrative medicine, Chopra Globals signature programs have been proven to improve overall well-being through a focus on physical, mental and spiritual health. Chopra Global has been at the forefront of health and wellness for more than two decades with a portfolio that includes an editorial archive of more than 2000 health articles, expansive self-care practices and meditations, a comprehensive mobile app, masterclasses, teacher certifications, immersive live events and personalized retreats. By providing tools, guidance and community, Chopra aims to advance a culture of well-being and make a healthy, peaceful and joyful life accessible to all. For more information, interact with the team onFacebook,TwitterandInstagram.

About Deepak Chopra:

Dr.Deepak Chopraisa world-renowned pioneer in integrative medicine and personal transformation. He isthe founder ofChopra GlobalandThe Chopra Foundation, a non-profit entity for research on well-being and humanitarianism.Chopra is a Clinical Professor of Family Medicine and Public Health at theUniversity of California, San Diegoand serves as a senior scientist with Gallup Organization.For the last thirty years, Chopra has been at the forefront of the meditation revolutionand has authored over 90 books translated into over forty-three languages, including numerousNew York Timesbestsellers.His newest book,Total Meditation(Harmony Book,September 2020) helps to achieve new dimensions of stress-free and joyful living.TIME magazine has described Dr. Chopra as one of the top 100 heroes and icons of the century.

For More Information:https://www.gtslivingfoods.com

Go here to see the original:
GT's Synergy Teams Up With Chopra Global For First-Ever National Partnership - BevNET.com

You might have missed it, but last week the UK Health Secretary Matt Hancock said that his government was recommending vitamin D supplements as a protective measure against the coronavirus.

But most of the attention focused on Mr Hancocks stumbling around on the issue. One moment he dismissed vitamin Ds usefulness, saying there was no good evidence as to its efficacy.

The next he was touting it as a must-take prophylactic because the evidence was pretty good, after all.

Theres certainly been a fair bit of faffing about on the issue.

A letter published three weeks ago in the British Medical Journal from an Australian doctor tells the story; more than 30 studies have demonstrated that having optimal blood levels of (vitamin D) reduces COVID-19 risks: reduced risk of infection; reduced risk of severe disease; reduced risk of dying.

The doctor, Peter J Lewis, a NSW GP with a special interest in integrative medicine, noted that Many researchers now regard the evidence as overwhelming.

Despite this, there still will be those who say that we need more research, but in the meantime, there is little to be lost and a huge amount to gain by recommending a decent daily dose of vitamin D3 for children and adults.

A comment piece published in Lancet in August made the same point while laying out the long history of vitamin Ds perceived potential as a treatment for respiratory illness. It goes back nearly 90 years.

In a study based at the Hospital Universitario Marqus de Valdecilla, 216 COVID-19 patients had their vitamin D levels measured. More than 80 per cent were found to have a vitamin D deficiency.

On average, men had lower vitamin D levels than women.

OK, one might argue, in the age of sunlight-phobia, that plenty of people are vitamin D deficient. Wheres the comparison with the broader population?

There wasnt one but, the doctors found that the patients with lower vitamin D levels also had raised serum levels of inflammatory markers such as ferritin and D-dimer.

Inflammation being the destructive hallmark of COVID-19, manifesting itself from the tip of the toes, to the lining of the blood vessels, the lungs and deep inside the brain.

Study co-author Dr Jos L. Hernndez, of the University of Cantabria, observed: Vitamin D is a hormone the kidneys produce that controls blood calcium concentration and impacts the immune system.

Vitamin D deficiency has been linked to a variety of health concerns, although research is still under way into why the hormone impacts other systems of the body. Many studies point to the beneficial effect of vitamin D on the immune system, especially regarding protection against infections.

He concludes:Vitamin D treatment should be recommended in COVID-19 patients with low levels of vitamin D circulating in the blood since this approach might have beneficial effects in both the musculoskeletal and the immune system.

He notes that supplements are especially important for high-risk individuals such as the elderly, patients with comorbidities, and nursing home residents, who are the main target population for the COVID-19.

For a technical explanation as to why vitamin D might work against COVID-19, see here.

More here:
Sunshine, salmon and a Spanish study: How Vitamin D affects the coronavirus - The New Daily

TORONTO, Oct. 28, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (CB2 or the Company), one of the largest multi-specialty healthcare systems in the United States, is pleased to announce that it has completed the asset acquisition of Tacoma-based medical clinic owned by Dr. Jackson (JMC) in University Place, Washington. The acquisition of JMC expands the Companys bricks and mortar and telemedicine services to 15 States.

JMC has been operating in Washington for over 20 years and has a growing patient base of over 10,000 from its operations. Services to patients include primary care and urgent care. Services provided by JMC are primarily reimbursed through insurance carriers including Medicare, Medicaid and other commercial payors. The Company can expect to leverage the expertise of management and operations across its network of existing clinics to further optimize organic growth activities.

The Company anticipates continued growth in patient registrations and visits as JMC continues to thrive among the challenges most clinics have faced due to the recent COVID-19 pandemic. Further, the Company will work quickly to expand on the current offering of services by leveraging its existing telemedicine infrastructure to provide access to patients across the state of Washington. The Company will also evaluate the current services offered to determine growth in new and complimentary medical services, add new lines of revenue from insurable services, and expand overall patient care. The Company will also launch its subscription-based telemedicine offering at $199/year designed to support the needs of uninsured American with urgent and acute care needs.

Our goal remains committed to establishing a national network of healthcare clinics to help millions of American gain access to affordable and accessible quality care, said Prad Sekar, CEO, CB2 Insights. With the expansion into Washington by way of acquisition, we welcome the opportunity to leverage our multi-disciplinary model to expand quickly on the services delivered by JMC to include telemedicine, sub-specialty, allied health and other complementary services for current and new patients of the practice.

JMC represents the second acquisition by the Company since its recently announced oversubscribed private placement of CAD 5.13 million in September 2020. The acquisition is also part of a 3-pronged growth model which includes growth from the current infrastructure, new services and acquisitions. The Companys experienced management team continues to develop a robust pipeline of accretive and strategic acquisition targets that are revenue generating, profitable and offer significant opportunities for growth. The Company paid a total cash consideration of CAD 0.37 million for JMC. Terms of the transaction include a customary transition by the previous owners for a period of up to 1 year to ensure successful continuity of care for patients in the practice. JMC reported revenues in 2019 of CAD 0.7 million and net income of CAD 0.1 million.

About CB2 Insights

CB2 Insights (CSE:CBII OTCQB:CBIIF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Companies mission to improve the lives of patients through the prevention and treatment of health conditions and using proprietary technology to monitor, assess, and generate insights to help improve patient outcomes. The Company owns and operates a proprietary virtual telehealth platform, and a network of over 30 medical clinics across 14 states in the US, providing multi disciplinary, primary and urgent care services to over 120,000 patients annually.

The Company has created works primarily to roster and treat patients seeking traditional and alternative treatments due to the ineffectiveness of conventional medicine, inability to find support through their existing care network, or in some cases, inability to access a primary care network. The Company offers both primary care via a traditional insurable services model and a disruptive low-cost subscription based urgent care offering for patients seeking immediate need to a healthcare provider via telehealth.

The Company differentiates itself by being one of the largest integrative medical practices in the US that owns its own proprietary technology, data analytical assets, and clinical research expertise to support new market expansion, market access, data collection and analysis and drug discovery.

The Company operates a proprietary electronic health record platform Sail (Sail) to document, treat, monitor and report on patient health outcomes. Developed in 2015, Sail is used internally across all of the Companys clinical operations. Sail features a robust telemedicine platform that the Company uses to provide care to its National patient base. To support patient care and positive health outcomes, the Company is also focused on advancing safety and efficacy research surrounding alternative health treatments by monitoring and assessing Real-World Data (RWD) and providing Real-World Evidence (RWE) through our proprietary technology, data analytics, and a full service contract research organization.

For more information please visit http://www.cb2insights.com or contact:

Investor RelationsJonathan L. Robinson CFAOak Hill Financialjrobinson@oakhillfinancial.ca416-669-1001

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in CB2s filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements regarding the Companys unaudited financial results and projected growth.

Although CB2 has attempted to identify important factors that could cause actual results, performance or achievements todiffer materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are subject to inconsistent legislation and regulation; change in laws; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and recreational-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. CB2 disclaims any intention or obligation to update or revise such information, except as required by applicable law, and CB2 does not assume any liability for disclosure relating to any other company mentioned herein.

No securities regulator or exchange has reviewed, approved, disapproved, or accepts responsibility for the content of this news release.

Read the original post:
CB2 Insights enters Washington with acquisition of Primary Care Medical Clinic with $0.7 million in Revenue and Positive EBITDA - BioSpace

AUSTIN, Texas Construction workers have a much higher risk of becoming hospitalized with the novel coronavirus than non-construction workers, according to a new study from researchers with The University of Texas at Austin COVID-19 Modeling Consortium.

Analyzing data from mid-March to mid-August on hospitalizations in Austin, Texas, the researchers found that construction workers there were five times as likely to be hospitalized with the coronavirus as workers in other occupations. The finding closely matches forecasts the team made in April.

The current study is, to the authors knowledge, the first to compare COVID-19 hospitalizations of construction workers to non-construction workers.An earlier study by the CDCreported that the construction sector was ranked number two in frequency of workplace outbreaks in Utah.

According to the researchers, the higher vulnerability for construction workers probably stems from the continuation of construction work throughout the pandemic, even during stay-home orders and other community-wide mitigation measures. The nature of the work exacerbated the risks due to close contact with others, practices by employers and demographic factors.

It doesnt necessarily mean we need to stop construction work, said Lauren Ancel Meyers, a professor of integrative biology and director of the consortium. It means we need to go to great lengths to ensure the health and safety of workers when they do go to work.

Encouraging basic precautions such as mask wearing and physical distancing on the work site would help, the authors note, as would having governments or employers offer workers paid sick leave and other incentives to stay home when they have a known exposure or have mild symptoms, to help mitigate risk. In addition, regular work site-based surveillance COVID-19 testing (with effective tracing and isolation of detected cases) can help prevent spread.

In central Texas, construction workers are disproportionately Hispanic, and many of them are uninsured or in close contact with people who have limited access to health care. Compared with the general population, they also experience more underlying health conditions linked to severe cases of COVID-19, are more likely to have more people in the home and may feel pressured to work even when they dont feel well due to socioeconomic pressures.

In Texas, COVID-19 has disproportionately affected Hispanics, who account for about 40% of the states population but 56% of its COVID-19 fatalities, according to the latest data from the Texas Department of State Health Services.

These workers face many overlapping risks and are being exposed at a time when less vulnerable populations are able to stay home, Meyers said.

Across the U.S., construction workers are disproportionately Hispanic: 17.6% of all workers are Hispanic or Latino, yet 30% of construction workers are Hispanic or Latino, according to theU.S. Bureau of Labor Statistics.

The studys other authors are Remy Pasco, graduate student in the Meyers lab; Spencer Fox, the consortiums associate director; Clay Johnston, dean of the Dell Medical School and vice president of medical affairs at UT Austin; and Michael Pignone, chair of the Department of Internal Medicine and interim chair of the Department of Population Health at Dell Med.

The results are published in the peer-reviewed journal JAMA Network Open, a subsidiary of the Journal of the American Medical Association.

In their earlier study delivered in the spring, at the request of the City of Austin, the team analyzed the risks of allowing construction work to continue during the pandemic. (On March 31, Texas Gov. Greg Abbott declared all construction essential and permissible statewide, overriding earlier local restrictions.) At the time, the team projected that construction workers would have a 4 to 5 times higher rate of hospitalization than non-construction workers a prediction the new paper bears out.

From mid-March to mid-August, the elevated risk of COVID hospitalization among construction workers matched our model predictions almost to a T, Pasco said. The rise in COVID-19 hospitalizations among construction workers suggest that the virus has been spreading at work sites, and more should be done to protect the health and safety of the workers.

Their model also predicted that continued construction work would increase the rates of hospitalizations among the general public because of increased transmission from construction workers, but with current levels of contact tracing, that is much harder to measure and validate, Meyers noted.

This study was supported, in part, by the U.S. Centers for Disease Control and Prevention and the National Institutes of Health.

The rest is here:
Curbing COVID-19 Hospitalizations Requires Attention to Construction Workers - UT News | The University of Texas at Austin

Dr. Andrew Weil, MD

Andrew Weil, MD,founder and director of theAndrew WeilCenter forIntegrative Medicineat the University of Arizonaand chief science officer for Maui Grown Therapies, will give a free online presentation entitled: Cannabis and the Anti-inflammatory Lifestyle, at 11 a.m. on Thursday, Nov. 5, 2020. A live Q&A will conclude the presentation.

Dr. Weilhas long advocated the anti-inflammatory lifestyle to improve health and wellness. Participants will learn how to reduce inflammation and boost the bodys natural defense mechanisms. Dr. Weil will also discus the compounds in the cannabis plant, such as CBD, THC and terpenes (aromatic oils).

Dr. Weil chairs Maui Grown Therapies stellar Science & Medical Advisory Board and has served as the companys chief science officer since 2015. Heis a clinical professor of internal medicine and founder and director of theWeil Center forIntegrative Medicine at the University of Arizona in Tucson.He earnedbothhis medical degree and his undergraduatedegree in biology (botany) from Harvard University.

Dr.Weil is also a best-selling authorof more than 80 books on health and wellness. He is also the founder ofTrue Food Kitchen, a national restaurant chain that features fresh, seasonal organic ingredients in its dishes. The restaurants are groundedin Dr. Weils philosophy thatfood should makepeoplefeel better, not worse.

Maui Grown Therapies is Hawaiis first state-licensed medical cannabis dispensary. Registration can be completed atwww.mauigrown.com.

Visit link:
Cannabis and the Anti-Inflammatory Lifestyle, Webinar on Nov. 5 - Maui Now

Melissa Young, MD, is a specialist in integrative medicine at the renowned Cleveland Clinic in the USA. In a recent article at the clinic, the migraine expert explains what people with chronic migraine can do to reduce the frequency and severity of migraine attacks without having to take medication for it.

Migraine sufferers are often struck by a debilitating pain that often forces them to retreat to a dark room and wait for the pain to subside. A specialist will present non-drug options to reduce the frequency and intensity of these attacks.

To escape the pain, migraine sufferers often resort to painkillers such as ibuprofen or prescription drugs. However, according to Dr. Young, this is not always necessary, because there are also natural and drug-free ways to combat migraine headaches. We have to consider nutrition, nutrient supply, sleep, fluid intake and stress, all of which are common triggers for migraines, the doctor explains. The following tips can help cushion the effects of migraines.

According to Dr. Young, the consumption of several small meals throughout the day helps to keep the blood sugar level stable. A stable blood sugar level in turn leads to fewer migraine attacks. With the kind of the nutrition one can orient oneself at the concept of the Mediterranean diet, which has a high portion of fruit, vegetable, beans, lean protein and healthy fats (e.g. from wild salmon, nuts, seeds and olive oil).

Pay attention to the triggers

Certain ingredients that are ingested through the diet are frequent triggers of migraine attacks. For example, caffeine or fried foods are possible triggers for many of those affected. Dr. Young recommends that it is always important to understand what was eaten on the day when a seizure occurs: Watch out for reactions to ripened cheese, chocolate, alcohol and fermented or pickled foods. Experience shows that the following ingredients are often involved:

There seems to be a connection between mitochondrial energy production in your cells and migraine, stresses Dr. Young. In migraines, he says, it is particularly important to consume the right amounts of coenzyme Q10, vitamin B2 and magnesium. Anyone who frequently suffers from migraine attacks should have a doctor check whether a nutrient deficiency exists.

In addition, chiropractic and acupuncture measures as well as massages also have a soothing effect on some migraine sufferers, according to the expert. Further tips can be found in the article: Natural household remedies for headaches. (vb)

Getting a grip on migraine attacks without drugs

Stress in everyday life is also a common trigger for tension headaches. Lifestyle changes and targeted stress management can reduce the number and severity of migraine attacks. I teach my patients meditation, including mindfulness and mantra meditation, says Dr. Young. Diaphragmatic breathing and the so-called 4-7-8 breathing technique are also effective ways to reduce stress.

Herbal therapies, for example with butterbur and feverfew, can also help prevent migraines, Dr. Young recommends. Butterbur can also help with seasonal allergy symptoms. Feverfew dilates the blood vessels and can thus help to prevent migraine attacks.

WashingtonNewsday Health and Wellness.

Read more:
Relieve migraine headaches without medication. - The Washington Newsday

HIGH POINT, N.C., Oct. 29, 2020 With growing enrollment for the 2020-21 academic year, High Point University welcomed nine new faculty members this year to the Nido R. Qubein School of Communication, Earl N. Phillips School of Business and David R. Hayworth College of Arts and Sciences.

These new faculty members are part of 25 total new faculty members to join HPU this fall. Click here to read more about 16 new faculty members who joined HPUs growing health and sciences programs.

Cameron Zinsou, Visiting Instructor of History

Cameron Zinsou teaches two sections of Foundations of Western Civilization and two sections of American Aspirations, 1914 to Present in HPUs David R. Hayworth College of Arts and Sciences. His area of expertise includes civil and military relations at the local level. He is also a specialist in the Operation Anvil/Dragoon, the allied invasion of southern France in August 1944.

Zinsous current research is about daily life in southern France during World War II. Specifically, hes looking into the definition of occupation and whether or not asovereign nationcan occupy its own citizens' property or possessions.

He previously taught as a teaching assistant at the University of North Texas and teaching assistant and instructor at Mississippi State University. He is also involved in the Society for Military History. He served as the graduate student representative for the Society and in 2017, and the society awarded him with the Allan R. Millett Dissertation Research Fellowship Award for his work.

History is ubiquitous, says Zinsou. It informs the way we live our lives presently, and conversations about our history permeate our daily life. I want to show our students how different people have interpreted separate events through time. I hope to make students aware that history is a living, breathing entity that is constantly revised and contested. The best interpretations of history are evidence-based and built off of the work of previous historians.

Dr. Alec Szalewski, Assistant Professor of Criminal Justice

As an assistant professor of criminal justice, Dr. Alec Szalewski teaches a variety of courses, such as probation, parole, and community corrections, in the David R. Hayworth College of Arts and Sciences. Szalewski will be conducting research, advising students and participating in service projects.

His area of expertise includes macro and micro level influences on lethal and non-lethal violence. His recent prior publications focus on homicide, specifically, intimate partner homicide and family homicide.

He earned his Ph.D. with an emphasis on criminology at the University of Central Florida, where he also taught as a graduate teaching associate. During his time at UCF, he also published four peer-reviewed journal articles, presented at conferences, and served as a reviewer for peer-reviewed academic articles. He was a recipient of the Office of Research and Commercialization (ORC) Doctoral Fellowship at the University of Central Florida for the 2017-2018 academic year.

Criminal justice and criminology are a deep topic that do not often have one answer or one perspective, says Szalewski. My goal for the students taking my courses is not only for them to learn the material through deeper discussion and interaction with each other, but to be able to extend that understanding past the basic subject matter. My classes challenge students to critically analyze and understand the topics as a whole and from other perspectives, even those perspectives that may not be agreed with. I believe this not only helps the students better learn the basic subject matter, but it gives them an opportunity to better recognize the concepts and ideas as a whole.

Dr. Abby Broughton, Assistant Professor of French

Dr. Abby Broughton teaches both the beginner and intermediate French series in HPUs David R. Hayworth College of Arts and Sciences. These courses introduce students to Francophone language and culture, help them build a strong foundation in French and are also the gateway into advanced language courses.

Her research focuses on developing the interpretive mode and critical cultural awareness in the French classroom. Most recently, she has been working with social reading technologies to transform students reading experience in French.

She has previously worked in France and holds a Bachelor of Arts in French and International Studies, a Master of Arts in French Language and Literature, and a Ph.D. in French and Second Language Studies. Broughton earned her doctoral degree at Vanderbilt University, where she combined her love of Francophone literature and passion for pedagogy in a degree that focused both on French and Second Language Studies. Broughton taught French while earning her masters and doctoral degrees and has experience in all levels of language study.

The majority of my students are in their first year, so it is exciting for me as a professor to be one of their first points of contact on campus, says Broughton. The skills they learn in these courses will serve them throughout their careers at High Point University and in their own lives as they navigate our interconnected world.

Dr. Humberto Gonzlez Chvez, Assistant Professor of Italian

Dr. Humberto Gonzalez Chavez

Dr. Humberto Gonzlez Chvez is teaching primarily elementary, intermediate and advanced language and culture courses in HPUs David R. Hayworth College of Arts and Sciences. He plans to develop new courses in his area of specialty and to collaborate in HPUs study abroad program in Sicily. Beyond teaching, he will co-lead co-curricular activities such as the Italian Club and the Tavola Italiana. He is currently working to found a chapter of Gamma Kappa Alpha, the national honor society for Italian, and hopes to induct its first class in spring 2021.

Gonzlez Chvez has been teaching Italian language, literature and culture for more than 10 years at universities in the United States and abroad. He has held appointments at Ohio State University, University of North Texas, Baylor University, Charles University in Prague and New York University. He also taught an intensive language course at the Yale School of Architecture. Gonzlez Chvez specializes in late medieval Italian literature with particular interest in Dantes Divine Comedy and Petrarchs Rerum vulgarium fragmenta.

He holds a Bachelor of Arts in music performance from Texas Christian University, a Master of Arts in Italian studies from Ohio State University, a Master of Arts in Italian language and literature from Yale University, and a Master of Philosophy and Ph.D. in Italian literature from New York University.

I hope that I am able to convey to my students that there is nothing that compares to learning to speak and understand another language, says Gonzlez Chvez. It gives you a profound insight into a different culture that you cannot achieve by studying any of its other artifacts. It also prepares you better than anything else for acquiring a deeper appreciation of those very artifacts which are at the center of other fields of inquiry from literature and art to science, political theory and philosophy.

Dr. Rodney Reynolds, Assistant Professor of Anthropology

Dr. Rodney Reynolds teaches in the Department of Sociology and Anthropology in HPUs David R. Hayworth College of Arts and Sciences. His courses focus on social and cultural anthropology, including medical anthropology. He has created and will teach a new honors course in the spring 2020 semester about material culture, which will explore the relationships and meanings that grow out human relationships with things.

Reynolds is an anthropologist and has worked in Latin America over the past few years, specifically in Mexico. While in Mexico, he was funded to explore obesity in family contexts. Last year, he completed a public engagement focused project around mindful walking that explored how well-being is generated through locomotion and attention to ones sensory environment. Reynolds is currently involved in a study with a Peru-based research group that seeks to describe and analyze how COVID-19 and quarantine has impacted people over 60 in one of Lima Perus low income neighborhoods.

He has been teaching and conducting research for more than a decade in anthropology and the social sciences. Reynolds holds a Ph.D. in anthropology and a masters degree in anthropology with a concentration in material culture, both from University College London.

I hope to create a learning environment conducive to inspired and critical dialogue among my students, says Reynolds.

Dr. Tanisha Watkins, Instructor of Communication

Dr. Tanisha Watkins teaches human communication and two graduate courses data decision-making and the MA-CBL Capstone, which are a part of HPUs new Masters in Communication and Business Leadership program. Watkins is also a member of HPUs Institutional Review Boards committee.

Watkins research revolves around improving adolescent sexual health outcomes by creating student-informed sex education curricula and developing social media campaigns. These interests were sparked when Watkins was pursuing her masters degree in the HPUs strategic communication program. Watkins continues to explore adolescent sexual health in school environments, and her current research explores how high school officials can work with local health departments to create, disseminate and evaluate student-informed sexual health curricula.

Her work has been featured at national and international conferences for the National Communication Association, the American Public Health Association, the Centers for Disease Control and Prevention, and the Society for the Scientific Study of Sexuality.

She received a Bachelor of Arts in Communication from the University of Miami, a Master of Arts in Strategic Communication from HPU and Ph.D. in Consumer Behavior from Purdue University.

Through memorable and lively class discussions, I want to show students how to use language and their voices to make change in the world, says Watkins.

Dr. Candice Edrington, Assistant Professor of Strategic Communication

Dr. Candice Edrington is teaching human communication, public relations techniques and mixed methods research and analysis, which is a graduate course in the strategic communication program, in HPUs Nido R. Qubein School of Communication. She serves on two thesis committees and is responsible for training the department on a new research software, Crimson Hexagon.

She brings experience in both quantitative and qualitative methods to HPU, where she explores digital activism by examining and analyzing the intersections of social movements, strategic communication and social media through a public relations lens. She has a passion for social justice and change that fuels the desire to uncover both visual and textual messaging strategies used in social movements that promote action and build relationships.

Edrington has professional experience in communication and public relations as an adjunct instructor, instructor of record, independent public relations consultant, coordinator of communications, interim academic affairs coordinator and director of engagement. She most recently served as editorial assistant for the Communication Education Journal.

She earned her Ph.D. in communication, rhetoric and digital media with emphasis in digital public relations from North Carolina State University, a masters degree in strategic communication with emphasis in public relations from High Point University, and bachelors degree in business administration with concentration in marketing from Winthrop University.

As an instructor, I hope to not only prepare students for careers in strategic communication and public relations, but to facilitate the co-creation of knowledge through critical thinking, relationship building and hands-on experience, says Edrington. In the classroom, I aim to foster a positive learning space where diversity and inclusion, most of all, and students ideas, are welcomed. High importance is placed on implementing assignments that are not only grounded in theory, but practical in nature.

Nakia Shelton, Assistant Professor of Strategic Communication

Nakia Shelton teaches graphic software packages, infographics, practicum in publicity methods and strategic message development in advertising in HPUs Nido R. Qubein School of Communication.

Her area of expertise includes design thinking, which is a creative problem-solving process that involves empathy and developing a deeper level of understanding about people in order to inform innovative and creative solutions. For her thesis, Shelton used design thinking to explore burnout among designers in the workplace and propose solutions.

This is Sheltons first position in academia, but she brings 15 years of experience as a designer and design manager in public and private sector institutions and companies. She has a Bachelor of Fine Arts in art with a concentration in graphic design from Longwood University. She earned her Master of Fine Arts in design thinking from Radford University.

By integrating and imparting my industry experience, I hope to provide real-world context to the subject matter through hands-on, interactive learning, while also encouraging and supporting students in reaching their full creative potential, says Shelton.

Dr. Greg Page, Assistant Professor of the Practice of Healthcare Management

Dr. Greg Page brings extensive experience in healthcare management to High Point Universitys Earl N. Phillips School of Business at a most opportune time with the creation of the new minor in healthcare management and a specialization in healthcare management within the MBA program. His areas of expertise include patient satisfaction, process improvement, lean processes, patient safety, revenue cycle operations and physician relations.

Over the last 23 years, Pages experience includes pharmaceutical sales, working in the start-up company that became Minute Clinic, serving as the healthcare administration officer onboard a nuclear powered aircraft carrier, a leadership position in revenue cycle operations in the Texas Medical Center and serving as the chief operating officer of a 125-bed community hospital. Page has also held leadership positions in post-acute care at a continuing care retirement community and at a rehabilitation and nursing center in the UNC Health System.

Page received the Navy and Marine Corps Commendation Medal for Meritorious Service while onboard the USS Nimitz during Operation Iraqi Freedom.

Page earned his doctorate in public health from the University of North Carolina at Chapel Hill; his MBA and Master of Healthcare Administration at the University of Minnesota; and his bachelors degree in economics at Southwestern University in Georgetown. He is also a fellow in the American College of Healthcare Executives (FACHE). Pages current and previous affiliations and board memberships include: board member American College of Healthcare Executives, Raleigh, North Carolina, Chapter; board member American College of Healthcare Executives, Charlotte, North Carolina, Chapter; board member of the Masters in Healthcare Administration Advisory Board, UNC-Charlotte; Health Reach Community Clinic, Integrative Medicine Task Force volunteer; Virginia B. Andes Volunteer Community Clinic, committee chair; and board member American Association of Healthcare Administrative Management, Texas, Chapter.

At High Point University, every student receives an extraordinary education in an inspiring environment with caring people. HPU, located in the Piedmont Triad region of North Carolina, is a liberal arts institution with 5,600 undergraduate and graduate students. It is ranked No. 1 by U.S. News and World Report for Best Regional Colleges in the South, No. 1 for Most Innovative Regional Colleges in the South and No. 1 for Best Undergraduate Teaching in the South. The Princeton Review named HPU in the 2021 edition of The Best 386 Colleges and on the Best Southeastern Colleges 2021 Best Colleges: Region by Region list. HPU was recognized as a Great School for Business Majors and a Great School for Communication Majors. HPU was also recognized for Best College Dorms (No. 1), Most Beautiful Campus (No. 9), Best Career Services (No. 19) and Most Active Student Government (No. 19). For 10 years in a row, HPU has been named a College of Distinction with special recognition for career development, business and education programs, and The National Council on Teacher Quality ranks HPUs elementary education program as one of the best in the nation. The university has 60 undergraduate majors, 63 undergraduate minors and 14 graduate degree programs. It is a member of the NCAA, Division I and the Big South Conference. Visit High Point University on the web at highpoint.edu.

Visit link:
HPU Announces New Faculty in Arts and Sciences, Communication and Business - Yes! Weekly

Researchers have long known that many people (mostly women) suffering from anorexia face a high risk of death. But, until now, they didnt know what causes the eating disorder to turn fatal.

In a research letter published in the Oct. 26 edition of Nature Metabolism, Yale researchers describe a specific neuron that appears to play an important role in whether anorexia becomes deadly.

They also discovered a potential treatment: a high-fat diet.

Over the last 25 years, our work has focused on understanding what drives hunger, said author Tamas Horvath, the Jean and David W. Wallace Professor of Comparative Medicine and professor of neuroscience and of obstetrics, gynecology, and reproductive sciences. We wondered if neurons in the brain which are working at a high level when someone is dieting could be participating in some aspect of the disease.

For the study, the researchers looked at a specific neuron that is active during food restriction, called the hypothalamic agouti-related peptide (AgRP), in food-restricted, exercising mice. They found a direct relationship between the workings of the neuron and the animals likelihood of dying. In fact, all animals on a food-restricted, high-exercise diet whose AgRP neurons were inhibited died within 72 hours.

If we diminished these neurons in animals who ate little and exercised compulsively, they died, said Horvath, who is also chair of the Department of Comparative Medicine and director of the Yale Program in Integrative Cell Signaling and Neurobiology of Metabolism.

Lowering levels of these neurons proved fatal, Horvath said, because they are needed to help the body access alternative forms of fuel namely fat in the absence of eating, combined with intense exercise. If these neurons dont function, you are not able to mobilize fuels from fat stores, he said.

But when they provided fatty food to the mice with decreased AgRP activity they found that death [was] completely prevented. This finding could suggest a new tactic for treating anorexia in people, Horvath said. If you are a person dying from anorexia and eat foods containing elevated fat, you may survive, he said.

Anorexia nervosa is an eating disorder that affects mainly adolescent girls. Those with the disorder severely restrict their eating, fear gaining weight, and exercise compulsively. Some 20 million women suffer from anorexia, which has the highest mortality rate of any mental illness.

Horvath and other Yale researchers are now extending their research to identify which fats may work best in preventing anorexia from becoming lethal. Many people with this disorder are in the care of medical professionals, and theres an opportunity to bring these findings to the human population, he said.

Other Yale researchers who contributed to the research letter include first author Maria Miletta, postdoctoral associate in comparative medicine; Onur Iyilikci, postdoctoral associate in comparative medicine; Marya Shanabrough, research associate in comparative medicine; Matija Sestan-Pesa, postdoctoral associate in comparative medicine; Caroline Zeiss, professor of comparative medicine; and Marcelo Dietrich, associate professor of comparative medicine and of neuroscience. The work was supported by the Klarman Family Foundation and the National Institutes of Health.

Go here to read the rest:
Yale finds neuron behind fatal anorexia, and solution in high-fat diet - Yale News